Patient was administered doses. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.; No Adverse Event; Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.), PRODUCT STORAGE ERROR (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.), PRODUCT STORAGE ERROR (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.) and PRODUCT STORAGE ERROR (Patient was administered doses after. Vaccine administered on 23FEB2023 after initially being stored in the refrigerator on 23JAN2023 from the bivalent Moderna covid-19 vaccine.).    Concomitant product use was not provided by the reporter. This case is related with 2nd patient case out of 6 adult patient case.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-713876 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2023: Live follow up has been appended which included suspect batch /lot number and case narrative were  updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713876:(Master Case pt 1 of 6)